TrialFind
Saved trials
Back to results
Unknown
Phase 2
Efficacy and Safety of Tamibarotene (OAM80) for Alzheimer's Disease
NCT01120002
What is this trial?
Generating plain-language summary...
Am I eligible?
Generating eligibility summary...
What's involved?
Summarizing study design...
Where and how to apply
Primary location
Osaka City University Hospital
Osaka, Japan
Contact
Takami Miki, MD
+81-6-6645-212
""miki."@med.osaka-cu.ac.jp"
View on ClinicalTrials.gov
Official details
Efficacy and Safety of Tamibarotene (OAM80) for Alzheimer's Disease — TrialFind